TimeTeller puts our internal clocks at the center of personalized medicine
German startup TimeTeller has developed a saliva test kit to help anyone understand their circadian rhythm; it aims to reduce side effects from cancer treatments.
TimeTeller, a German startup, is revolutionizing personalized medicine by focusing on an individual's circadian rhythm. CEO Angela Relógio, a physicist-engineer and molecular biologist, founded TimeTeller after leaving academia to research oncology, circadian biology, and systems medicine. The company's saliva test kit helps people understand their circadian rhythm, which can be used to optimize cancer treatment and improve outcomes by timing treatment to a patient's internal clock.
Relógio is cautious about the test's capabilities, noting that it operates on two timelines: determining when cancer treatments will be more effective and tolerable, and providing personalized advice on sleep, nutrition, light exposure, and physical activity. TimeTeller has partnered with Germany's largest health insurance provider, Techniker Krankenkasse, to make the test more accessible to cancer patients.
The company's ambitions extend beyond cancer, with potential applications in metabolic diseases, neurodegenerative diseases, performance, and women's health. Relógio emphasizes the importance of timing in precision medicine, stating that "almost every process in our body is timed."
Written by urgent.news from TechCrunch's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
